Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Applied and Environmental Microbiology|April 1, 2000
Influence of catalase and superoxide dismutase on ozone inactivation of Listeria monocytogenesC W Fisher, D Lee, B A Dodge, et al.
Cytogenetics and Cell Genetics|January 1, 1991
Localization of the dihydrolipoamide branched-chain transacylase gene (DBT) of the human branched-chain keto acid dehydrogenase complex to chromosome 1K S Lau, R L Eddy, T B Shows, et al.
The Journal of Biological Chemistry|February 25, 1989
Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complexC W Fisher, J L Chuang, T A Griffin, et al.
The Journal of Clinical Investigation|September 1, 1991
Maple syrup urine disease in Mennonites. Evidence that the Y393N mutation in E1 alpha impedes assembly of the E1 component of branched-chain alpha-keto acid dehydrogenase complexC R Fisher, J L Chuang, R P Cox, et al.
Biochemical and Biophysical Research Communications|January 31, 1991
A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34C W Fisher, K S Lau, C R Fisher, et al.
Molecular Biology & Medicine|February 1, 1991
Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complexD T Chuang, C W Fisher, K S Lau, et al.
American Journal of Human Genetics|February 1, 1993
Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutationsC W Fisher, C R Fisher, J L Chuang, et al.
Mutation Research|May 4, 1999
Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studiesM Kranendonk, F Carreira, P Theisen, et al.
Mutation Research|February 19, 1999
Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systemsM Kranendonk, C W Fisher, R Roda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 6, 1992
High-level expression of functional human cytochrome P450 1A2 in Escherichia coliC W Fisher, D L Caudle, C Martin-Wixtrom, et al.
Pageof 4